SCHEMBL23286239

SCHEMBL23286239

COCCNc1nc(C(=O)OC)ccc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 3/20 0.44
MAPK8 P45983 1/20 0.43
MAPK9 P45984 1/20 0.43
MAPK10 P53779 1/20 0.43
ALDH1A1 P00352 6/20 0.41
HPGD P15428 2/20 0.41
CYP1A2 P05177 4/20 0.40
CYP3A4 P08684 4/20 0.40
ALOX15 P16050 3/20 0.40
USP2 O75604 2/20 0.40
CLK4 Q9HAZ1 2/20 0.40
TP53 P04637 1/20 0.40
APEX1 P27695 1/20 0.40
CASP7 P55210 1/20 0.40
LDHA P00338 1/20 0.40
HCAR3 P49019 1/20 0.39
PDE10A Q9Y233 1/20 0.38
NCF1 P14598 1/20 0.37
HSD17B10 Q99714 3/20 0.37
KDM4E B2RXH2 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23753892 0.79 ALDH1A1 (0.36) PTGER4ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL29737942 0.79 HCAR3 (0.48) PTGER4ALDH1A1HPGDHCAR3KDM4E
SCHEMBL23286240 0.79 HCAR3 (0.48) PTGER4ALDH1A1HPGDHCAR3KDM4E
SCHEMBL23767637 0.78 PTGER4 (0.48) PTGER4ALDH1A1HPGDALOX15LDHA
SCHEMBL23286161 0.78 ALDH1A1 (0.35) PTGER4ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL29393618 0.76 LDHA (0.43) PTGER4ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL198171 0.76 LDHA (0.43) PTGER4ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL23767655 0.75 MBOAT4 (0.36) PTGER4MAPK8MAPK9MAPK10ALDH1A1
SCHEMBL13824469 0.75 KDM4E (0.44) PTGER4ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL23703569 0.74 PTGER4 (0.34) PTGER4ALDH1A1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023169436-A1 BENZO BICYCLIC COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF 广州市联瑞制药有限公司 2023-09-14 WO disclosed
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 US disclosed
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 US disclosed
US-20230165846-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-06-01 US disclosed
CN-115697999-A Heterocyclic GLP-1 agonists 加舒布鲁姆生物公司 2023-02-03 CN disclosed
CN-114630823-A GLP-1R modulating compounds 吉利德科学公司 2022-06-14 CN disclosed
WO-2021160127-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2021-08-19 WO disclosed
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2021-06-10 US disclosed
WO-2021081207-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2021-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165846-A1 HETEROCYCLIC GLP-1 AGONISTS GLP1R, GIPR, GCGR PTGER4 329/4885MAPK8 1760/4885MAPK9 2487/4885
US-11702404-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 PTGER4 996/4885MAPK8 1332/4885MAPK9 1091/4885
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 PTGER4 996/4885MAPK8 1332/4885MAPK9 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.